| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |